Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma
NCT06146127
·
clinicaltrials.gov ↗
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Liver Cancer
Interventions
OTHER:
phenotyping
Sponsor
Inserm U955